{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:36Z","timestamp":1772166216302,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is limited literature in paediatric rheumatology describing holistic lived experiences of medical treatment from perspectives of children and young people (CYP) and their parents or carers (PC). This is important as it could have implications for adherence. This study aimed to explore treatment experiences of CYP and PC in a paediatric rheumatology service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were recruited at a day-case unit for intravenous infusions at a tertiary paediatric rheumatology centre. Joint qualitative semi-structured interviews with CYP and PC were used to collect data. Data were transcribed, quality checked and thematically analysed using NVivo 12.4 to identify findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-two participants (15 CYP between the ages of 6 and 16 years, 17 PC) took part in interviews lasting 41\u00a0min and 43\u00a0s, on average. Participants described experiences using infliximab, followed by tocilizumab and abatacept. Participants experienced a wave, oscillating between positive and negative trajectories. Experiences of medical treatments were described as temporary, eventually changing and leading to treatment changes or cessation. Behaviours were influenced through somatic factors (pain, function), social factors (advice from health professionals, encouragement from friends, family and teachers, practicality of using treatment in relation to school, work and finance) and cognitive factors (fear of needles, fear of specific medications, beliefs about necessity).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, findings demonstrate experiences of medical treatment reflect the nature of many paediatric rheumatology conditions, oscillating between periods of positive and negative trajectories. Somatic, social and cognitive experiences can be positive, when treatment is considered \u2018successful\u2019. Negative somatic, social or cognitive experiences led to behaviours such as treatment non-adherence. A limitation of the study is interviews were conducted jointly with CYP and PC, which may have influenced what participants were willing to say in front of one another however this does mean findings relate to both CYP and PC and so could be suitable targets for interventions to improve adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-025-01063-w","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T04:29:36Z","timestamp":1737606576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A qualitative study exploring experiences of treatment in paediatric rheumatology - children\u2019s, young people\u2019s, parents\u2019 and carers\u2019 perspectives"],"prefix":"10.1186","volume":"23","author":[{"given":"Kassie Gracella","family":"Putri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Lucy","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-0533","authenticated-orcid":false,"given":"Adam Pattison","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"6","key":"1063_CR1","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/rheumatology\/keab714","volume":"61","author":"R Costello","year":"2022","unstructured":"Costello R, et al. Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000\u20132018: results from the Clinical Practice Research Datalink. Rheumatology. 2022;61(6):2548\u201354.","journal-title":"Rheumatology"},{"issue":"10","key":"1063_CR2","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1093\/rheumatology\/keac064","volume":"61","author":"H Lythgoe","year":"2022","unstructured":"Lythgoe H, et al. Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. Rheumatology. 2022;61(10):4097\u2013106.","journal-title":"Rheumatology"},{"key":"1063_CR3","unstructured":"Myositis UK. Juvenile dermatomyositis [Homepage on the Internet]. 2024."},{"key":"1063_CR4","doi-asserted-by":"crossref","unstructured":"Ch\u00e9deville G, et al. Parent-reported Medication Side effects and their impact on Health\u2010Related Quality of Life in Children with Juvenile Idiopathic Arthritis. Volume 74. Arthritis Care & Research; 2022;74(10):1567\u201374.","DOI":"10.1002\/acr.24610"},{"key":"1063_CR5","unstructured":"England NHS. 2023, NHS England: Accessed at https:\/\/www.england.nhs.uk\/get-involved\/cyp\/ on 18\/04\/2024."},{"key":"1063_CR6","doi-asserted-by":"crossref","unstructured":"Abdwani R. Pediatric Rheumatology. Skills in Rheumatology. Springer: Singapore; 2021. H. Almoallim, Cheikh, M., Editor.","DOI":"10.1007\/978-981-15-8323-0_24"},{"issue":"7","key":"1063_CR7","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S2665-9913(22)00106-0","volume":"4","author":"EM Smith","year":"2022","unstructured":"Smith EM, et al. Research priority setting for paediatric rheumatology in the UK. Lancet Rheumatol. 2022;4(7):e517\u201324.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"1063_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12969-023-00849-0","volume":"21","author":"K Toupin-April","year":"2023","unstructured":"Toupin-April K, et al. I\u2019d like more options! Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis. Pediatr Rheumatol. 2023;21(1):74.","journal-title":"Pediatr Rheumatol"},{"issue":"4","key":"1063_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/anr.1790020407","volume":"2","author":"KB Pieper","year":"1989","unstructured":"Pieper KB, et al. Improving compliance with prednisone therapy in pediatric patients with rheumatic disease. Arthritis Rheumatism: Official J Am Coll Rheumatol. 1989;2(4):132\u20135.","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"issue":"3","key":"1063_CR10","first-page":"A40","volume":"2","author":"MA Rapoff","year":"1989","unstructured":"Rapoff MA. Compliance with treatment regimens for pediatric rheumatic diseases. Arthr Rhuem. 1989;2(3):A40\u20137.","journal-title":"Arthr Rhuem"},{"issue":"1","key":"1063_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10198-016-0786-1","volume":"17","author":"A Kuhlmann","year":"2016","unstructured":"Kuhlmann A, et al. Social\/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. Eur J Health Econ. 2016;17(1):79\u201387.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1063_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.22463","volume":"57","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, et al. Economic impact of juvenile idiopathic arthritis. Arthritis Care Research: Official J Am Coll Rheumatol. 2007;57(1):44\u20138.","journal-title":"Arthritis Care Research: Official J Am Coll Rheumatol"},{"issue":"1","key":"1063_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/annrheumdis-2014-206439","volume":"75","author":"J Haschka","year":"2016","unstructured":"Haschka J, et al. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis. 2016;75(1):45\u201351.","journal-title":"Ann Rheum Dis"},{"key":"1063_CR14","doi-asserted-by":"crossref","unstructured":"McGrady ME et al. Systematic review and meta-analysis of interventions to promote medication adherence among children, adolescents, and young adults with medical conditions. J Pediatr Psychol, 2024: p. jsae036.","DOI":"10.1093\/jpepsy\/jsae036"},{"key":"1063_CR15","doi-asserted-by":"crossref","unstructured":"Pearce CJ et al. Adherence to medicine in adolescence. The Transition of Respiratory Care: from Child to Adult (ERS Monograph). Sheffield, European Respiratory Society, 2024: pp. 54\u201365.","DOI":"10.1183\/2312508X.10011223"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"820586","DOI":"10.3389\/fped.2022.820586","volume":"10","author":"MM Kostik","year":"2022","unstructured":"Kostik MM, et al. The safety and efficacy of tofacitinib in 24 cases of pediatric rheumatic diseases: single centre experience. Front Pead. 2022;10:820586.","journal-title":"Front Pead"},{"key":"1063_CR17","doi-asserted-by":"crossref","unstructured":"Ruiz F, et al. A review of paediatric injectable drug delivery to inform the study of product acceptability\u2013An introduction. European Journal of Pharmaceutics and Biopharmaceutics; 2023.","DOI":"10.1016\/j.ejpb.2023.04.010"},{"issue":"9","key":"1063_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/acr.23758","volume":"71","author":"L Grisanti","year":"2019","unstructured":"Grisanti L, et al. Patient perspectives on intravenous biologics for rheumatologic disease. Arthritis Care Res. 2019;71(9):1234\u201342.","journal-title":"Arthritis Care Res"},{"key":"1063_CR19","doi-asserted-by":"crossref","unstructured":"Bolge SC et al. Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn\u2019s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Patient Prefer Adherence, 2017: pp. 661\u20139.","DOI":"10.2147\/PPA.S121032"},{"key":"1063_CR20","doi-asserted-by":"publisher","first-page":"237796081875944","DOI":"10.1177\/2377960818759442","volume":"4","author":"T Orenius","year":"2018","unstructured":"Orenius T, et al. Fear of injections and needle phobia among children and adolescents: an overview of psychological, behavioral, and contextual factors. SAGE Open Nurs. 2018;4:2377960818759442.","journal-title":"SAGE Open Nurs"},{"key":"1063_CR21","doi-asserted-by":"crossref","unstructured":"Karaatmaca B, et al. The impact of skin prick testing on pain perception and anxiety in children and parents. Allergologia et immunopathologia; 2021;49(2).","DOI":"10.15586\/aei.v49i2.68"},{"issue":"1","key":"1063_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/ijerph18010152","volume":"18","author":"G Bassi","year":"2021","unstructured":"Bassi G, et al. Parental stress, anxiety and depression symptoms associated with self-efficacy in paediatric type 1 diabetes: a literature review. Int J Environ Res Public Health. 2021;18(1):152.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"1063_CR23","first-page":"173","volume":"60","author":"HE Konak","year":"2022","unstructured":"Konak HE, et al. Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center. Rom J Intern Med. 2022;60(3):173\u201381.","journal-title":"Rom J Intern Med"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/978-1-4419-1005-9_1220","volume-title":"Encyclopedia of behavioral medicine","author":"PA Mora","year":"2013","unstructured":"Mora PA, McAndrew LM. Common-sense model of self-regulation. Encyclopedia of behavioral medicine. New York: New York, NY: Springer; 2013. pp. 460\u20137. M.D. Gellman and J.R. Turner, Editors."},{"issue":"3","key":"1063_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/17437199.2021.1878050","volume":"16","author":"MS Hagger","year":"2022","unstructured":"Hagger MS, Orbell S. The common sense model of illness self-regulation: a conceptual review and proposed extended model. Health Psychol Rev. 2022;16(3):347\u201377.","journal-title":"Health Psychol Rev"},{"issue":"5","key":"1063_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3899\/jrheum.171087","volume":"45","author":"LA Favier","year":"2018","unstructured":"Favier LA, et al. Barriers to adherence in juvenile idiopathic arthritis: a Multicenter Collaborative Experience and preliminary results. J Rheumatol. 2018;45(5):690\u20136.","journal-title":"J Rheumatol"},{"issue":"9","key":"1063_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/030802260206500904","volume":"65","author":"CA Britton","year":"2002","unstructured":"Britton CA, Moore A. Views from the inside, part 2: what the children with arthritis said, and the experiences of siblings, mothers, fathers and grandparents. Br J Occup Therapy. 2002;65(9):413\u20139.","journal-title":"Br J Occup Therapy"},{"key":"1063_CR28","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.pedn.2017.07.007","volume":"37","author":"W Yuwen","year":"2017","unstructured":"Yuwen W, et al. Struggling in the dark to help my child: parents\u2019 experience in caring for a young child with juvenile idiopathic arthritis. J Pediatr Nurs. 2017;37:e23\u20139.","journal-title":"J Pediatr Nurs"},{"key":"1063_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0280-7","volume":"16","author":"LdF Keppeke","year":"2018","unstructured":"Keppeke LdF, et al. Psychological characteristics of caregivers of pediatric patients with chronic rheumatic disease in relation to treatment adherence. Pediatr Rheumatol. 2018;16:1\u201311.","journal-title":"Pediatr Rheumatol"},{"issue":"12","key":"1063_CR30","doi-asserted-by":"publisher","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne R, et al. Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns Framework. PLoS ONE. 2013;8(12):e80633.","journal-title":"PLoS ONE"},{"issue":"2","key":"1063_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jcpt.13288","volume":"46","author":"AP Rathbone","year":"2021","unstructured":"Rathbone AP, et al. A qualitative study exploring the lived experience of medication use in different disease states: linking experiences of disease symptoms to medication adherence. J Clin Pharm Ther. 2021;46(2):352\u201362.","journal-title":"J Clin Pharm Ther"},{"key":"1063_CR32","unstructured":"Rathbone A. A phenomenological investigation of patients\u2019 lived experiences of medicines adherence: a novel perspective for future intervention development. Durham University; 2017."},{"issue":"3","key":"1063_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.pec.2003.04.003","volume":"55","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns. 2004;55(3):339\u201344.","journal-title":"Patient Educ Couns"},{"key":"1063_CR34","unstructured":"Royal Victoria Infirmary (RVI) and \u200c. 2017."},{"key":"1063_CR35","doi-asserted-by":"crossref","unstructured":"Crotty MJ. The foundations of social research: Meaning and perspective in the research process. The foundations of social research, 1998: pp. 1-256.","DOI":"10.4324\/9781003115700-1"},{"issue":"2","key":"1063_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7748\/nr2003.01.10.2.50.c5888","volume":"10","author":"H Priest","year":"2002","unstructured":"Priest H. An approach to the phenomenological analysis of data. Nurse Researcher (through 2013). 2002;10(2):50.","journal-title":"Nurse Researcher (through 2013)"},{"key":"1063_CR37","unstructured":"Halld\u00f3rsd\u00f3ttir S. The Vancouver school of doing phenomenology. Qualitative research methods in the service of health, 2000: pp. 47\u201381."},{"key":"1063_CR38","doi-asserted-by":"crossref","unstructured":"Moustakas C. Phenomenological research methods. sage; 1994.","DOI":"10.4135\/9781412995658"},{"issue":"2","key":"1063_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/EFI-2004-22201","volume":"22","author":"AK Shenton","year":"2004","unstructured":"Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inform. 2004;22(2):63\u201375.","journal-title":"Educ Inform"},{"key":"1063_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-021-00531-3","volume":"19","author":"T Rapley","year":"2021","unstructured":"Rapley T, et al. Snakes & Ladders\u2019: factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis\u2013a qualitative study. Pediatr Rheumatol. 2021;19:1\u201311.","journal-title":"Pediatr Rheumatol"},{"issue":"9","key":"1063_CR41","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acr.21695","volume":"64","author":"A Tong","year":"2012","unstructured":"Tong A, et al. Children\u2019s experiences of living with juvenile idiopathic arthritis: a thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken). 2012;64(9):1392\u2013404.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1063_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12969-016-0073-9","volume":"14","author":"O G\u00f3mez-Ram\u00edrez","year":"2016","unstructured":"G\u00f3mez-Ram\u00edrez O, et al. A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):13.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"1063_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.berh.2018.02.001","volume":"31","author":"CM Hedrich","year":"2017","unstructured":"Hedrich CM, Smith EM, Beresford MW. Juvenile-onset systemic lupus erythematosus (jSLE)\u2013Pathophysiological concepts and treatment options. Best Pract Res Clin Rheumatol. 2017;31(4):488\u2013504.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1063_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpeds.2014.03.042","volume":"165","author":"EA Lipstein","year":"2014","unstructured":"Lipstein EA, Dodds CM, Britto MT. Real life clinic visits do not match the ideals of shared decision making. J Pediatr. 2014;165(1):178\u201383. e1.","journal-title":"J Pediatr"},{"key":"1063_CR45","doi-asserted-by":"crossref","unstructured":"Nelson AJ, Pagidipati NJ, Bosworth HB. Improving medication adherence in cardiovascular disease. Nat Reviews Cardiol, 2024: pp. 1\u201313.","DOI":"10.1038\/s41569-023-00972-1"},{"issue":"4","key":"1063_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.pcl.2018.04.008","volume":"65","author":"GC Higgins","year":"2018","unstructured":"Higgins GC. Complications of treatments for Pediatric Rheumatic diseases. Pediatr Clin North Am. 2018;65(4):827\u201354.","journal-title":"Pediatr Clin North Am"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01063-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01063-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01063-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:21:04Z","timestamp":1751008864000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01063-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01063-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4358169\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was given the Faculty of Medical Sciences Research Ethics Committee (Reference number 33823\/2023) and the project was registered on the Trust\u2019s Clinical Effectiveness Register.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that all authors have approved the manuscript for submission. Also, I, Adam Pattison Rathbone, confirm that the manuscript has not been published, and have not been submitted for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"KGP was an MRes student working under the supervision of SS and APR. SS is a Paediatric Rheumatology Consultant in at the Great North Children\u2019s Hospital, AM is a Reader in Pharmacy Practice at Liverpool John Moore\u2019s Hospital, CLR is a Senior Lecturer in Pharmacy Practice at Newcastle University, and APR is a Lecturer in Clinical and Social Pharmacy at Newcastle University and Advanced Clinical Pharmacist at the Children\u2019s Hospital.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author information"}}],"article-number":"7"}}